Clinical Trial Update: Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating tolerability, safety, and preliminary efficacy of RKI983 eye drops in subjects with primary open-angle glaucoma and ocular hypertensi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• RKI983 Eye Drops (RKI983)

Snippet

Sponsor: Novartis | Conditions: Glaucoma, Ocular Hypertension | Phase 1 | Status: COMPLETED